References

  1. Committee on Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA); Board on Health Sciences Policy; Institute of Medicine; Field MJ, Boat TF, editors. Safe and Effective Medicines for Children: Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act. Washington (DC): National Academies Press (US); 2012 Feb 29. Google Scholar

  2. World Health Organization. State of the world’s vaccines and immunization; World Health Organization, Global Programme for Vaccines and Immunization, 1211 Geneva 27, Switzerland 1996; WHO/GPV/96.04. Accessed November 28, 2013

  3. Weldegebriel GG, Gasasira A, Harvey P, Masresha B et al. Measles resurgence following a nationwide measles vaccination campaign in Nigeria, 2005-2008. J Infect Dis. 2011; 204 Suppl 1: S226-31. PubMed | Google Scholar

  4. Ophori Endurance A, Tula Musa Y, AzihAzuka V et al. Current Trends of Immunization in Nigeria: Prospect and Challenges. Trop Med Health. 2014; 42(2): 67-75. PubMed | Google Scholar

  5. Bankole Munir A, Olusegun Kola-Korolo, Marian Bankole N et al. The impact of health facility monitoring on cold chain management practices in Lagos, Nigeria. Journal of Public Health and Epidemiology. 2010; 2(4): 78-81. PubMed | Google Scholar

  6. Oli Angus Nnamdi, Agu Remigus Uchenna, Oli Ugochukwu Chinedum et al. Safety evaluation in mice of the childhood immunization vaccines from two south-eastern states of Nigeria. Asian Pac J Trop Biomed. Feb 2015; 5(2): 132-137. PubMed | Google Scholar

  7. Naik AK, Rupani MP, Bansal RK. Evaluation of vaccine cold chainin urban health centers of Municipal Corporation of Surat city, Western India. Int J Prev Med. 2013 Dec; 4(12): 1395-401. PubMed | Google Scholar

  8. Shrivastava SR, Shrivastava PS, Ramasamy J. Strengthening cold chain mechanism to enhance the effectiveness of immunization program. Int J Adv Med Health Res. 2015; 2: 63-4. PubMed | Google Scholar

  9. Onuzulike Ifeoma Joy. An assessment of the cold chain system in immunization centers in Enugu north Local Government Area of Enugu state. A project presented to the Department of Community Medicine College of Medicine, University of Nigeria Enugu campus. 2013. Google Scholar

  10. Saleh JEA. Trends of measles in Nigeria: A systematic review. Sahel Med J (serial online). 2016; 19: 5-11. PubMed | Google Scholar

  11. National Population Commission: Population Distribution by Sex, State, LGA & Senatorial district; Federal Republic of Nigeria, 2006 Population and Housing Census: PRIORITY TABLE, Volume III (April, 2010). Google Scholar

  12. Arciniega JL, Dominguez-Castillo RI. Development and Validation of Serological Methods for Human Vaccine Potency Testing: Case Study of an Anthrax Vaccine. Procedia in Vaccinology 5 (2011) 213 – 220. Google Scholar

  13. GraphPad Prism 7 - for Mac and Windows
  14. Samant Y, Lanjewar H, Parker D, Block L, Tomar GS, Stein B. Evaluation of the Cold-Chain for Oral Polio Vaccine in a Rural District of India. Public Health Reports. 2007; 122(1): 112-121. PubMed | Google Scholar

  15. Kumru Ozan S, Joshi Sangeeta B, Smith Dawn E et al. Vaccine instability in the cold chain: Mechanisms, analysis and formulation strategies. Biologicals. 2014; 42: 237e259. Google Scholar

  16. Umeh Chukwuemeka Anthony, Ahaneku Hycienth Peterson. The impact of declining vaccination coverage on measles control: a case study of Abia state Nigeria. Pan African Medical Journal. 2013; 15: 105. PubMed | Google Scholar

  17. Cohen Bernard J, Audetb Susette, Andrewsa Nick, Beeler Judy. Plaque reduction neutralization test for measles antibodies: description of a standardized laboratory method for use in immunogenicity studies of aerosol vaccination. Vaccine. 2007; 26: 59-66. PubMed | Google Scholar

  18. Cohen BJ, Parry RP, Doblas D, Samuel D, Warrener L et al. Measles immunity testing: comparison of two measles IgG ELISAs with plaque reduction neutralisation assay. J Virol Methods. 2006;131(2): 209-12. PubMed | Google Scholar

  19. Chen RT, Markowitz LE, Albrecht P, Stewart JA et al. Measles antibody: re-evaluation of protective titers. J Infect Dis. 1990; 162(5): 1036-42. PubMed | Google Scholar

  20. García-León ML, Bonifaz LC, Espinosa-Torres B et al. A correlation of measles specific antibodies and the number of plasmacytoid dendritic cells is observed after measles vaccination in 9 month old infants. Human Vaccines & Immunotherapeutics. 2015; 11(7): 1762-1769. Google Scholar

  21. Ogbuanu Ikechukwu U, Kutty Preeta K, Hudson Jean M et al. Impact of a Third Dose of Measles-Mumps-Rubella Vaccine on a Mumps Outbreak. Pediatrics. 2012; 130(6). PubMed | Google Scholar

  22. Umeh CA, Onyi SC. Case based rubella surveillance in Abia State, South East Nigeria, 2007–2011. Peer J. 2014 Sep 30; 2: e580. PubMed | Google Scholar

  23. Oli Angus Nnamdi, Oli Ugochukwu Chinedum et al. An assessment, in mice, of the safety of the childhood immunization vaccines sourced from three south-eastern states of Nigeria. Trials in Vaccinology. 2016; 5: 8-14. Google Scholar